Literature DB >> 303925

Heroic treatment for fulminant hepatic failure?

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 303925      PMCID： PMC1632546          DOI： 10.1136/bmj.2.6098.1301

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

Review 1.  Pathogenesis and therapy of hepatic coma.

Authors:  J E Fischer; R J Baldessarini
Journal:  Prog Liver Dis       Date:  1976

Review 2.  Hepatic encephalopathy: current status.

Authors:  S Schenker; K J Breen; A M Hoyumpa
Journal:  Gastroenterology       Date:  1974-01       Impact factor: 22.682

3.  Long term follow-up studies of patients surviving fluminant viral hepatitis.

Authors:  G G Karvountzis; A G Redeker; R L Peters
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

Review 4.  The management of fulminant hepatic failure.

Authors:  C Trey; C S Davidson
Journal:  Prog Liver Dis       Date:  1970

5.  Exchange transfusion in fulminant hepatic failure.

Authors:  T B Reynolds
Journal:  Gastroenterology       Date:  1969-01       Impact factor: 22.682

6.  Letter: Randomization of corticosteroid therapy in fulminant hepatitis.

Authors:  A G Redeker; I L Schweitzer; H S Yamahiro
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

7.  Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis.

Authors:  D B Silk; P N Trewby; R A Chase; P J Mellon; M A Hanid; M Davies; P G Langley; P G Wheeler; R Williams
Journal:  Lancet       Date:  1977-07-02       Impact factor: 79.321

8.  Acid-base and metabolic disturbances in fulminant hepatic failure.

Authors:  C O Record; R A Iles; R D Cohen; R Williams
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

9.  Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.

Authors:  B G Gazzard; M L Lewis; G Ash; C R Rizza; E Bidwell; R Williams
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

10.  H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials.

Authors:  B R Macdougall; R J Bailey; R Williams
Journal:  Lancet       Date:  1977-03-19       Impact factor: 79.321
  10 in total
  1 in total

Review 1.  Dietary prevention of ischaemic heart disease--a policy for the '80s.

Authors:  B Lewis
Journal:  Br Med J       Date:  1980-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.